Leading the way in finding new treatments for brain diseases
Researchers at URMC have been pioneers in understanding the role that astrocytes (pictured here) play in the human brain and how manipulating these previously overlooked cells could lead to new ways to treat a host of neurological disorders.
The University of Rochester is one of the nation’s leading centers for research and care in neurological disorders. URMC is ranked among the top 10 in the nation in the amount of research funding it receives from the National Institutes of Health to study diseases of the central nervous system.
Neuromedicine research is spread across the University and ranges from efforts to understand:
How the brain’s neural networks help us understand the world around us and shape behavior,
The development and function of the complex and interconnected network of cells that comprise the central nervous system, and how age, injury, environmental factors, genetics, and infection can give rise to neurological disorders; and
How new technologies – such as telemedicine and mobile apps – can improve access to care and empower patients.
The mPower app is being used as part of a study that collects data from Parkinson’s patients in an effort to better understand how the disease impacts daily life.
Medical Center physicians and scientists have long been recognized for their leadership in translating scientific discoveries into new ways to diagnose, prevent, and treat both rare and more common neurological disorders. URMC serves as the hub of several global networks of researchers seeking new treatments for a range of neurodegenerative diseases, like Parkinson’s disease, Huntington’s disease, and muscular dystrophy. Our researchers are also leading efforts to improve stroke care, reduce the risk of concussions, and help develop new treatments for multiple sclerosis, epilepsy, Alzheimer’s, ALS, and back pain.